Mohamed Abdel Moneim: Proud to Contribute to 2 Publications on Obesity and VTE Risk
Mohamed Abdel Moneim, Clinical Associate Professor at University of Sharjah, shares a posy on LinkedIn:
“I’m proud to contribute to two publications on obesity and Venous Thrmoboembolism an important area of research, as obesity remains a major risk factor for venous thromboembolism (VTE).
Assessing the risk, alongside identifying optimal treatment strategies with Enoxaparin, remains critical for healthcare professionals.”
Title 1: Venous Thromboembolism and Bleeding Risk in a Population with Obesity Hospitalized for Surgery and Receiving Enoxaparin for Thromboprophylaxis
Authors: Walter Ageno, Marc Carrier, Christine Stroh, Yasmina Djoudi, Mohamed Abdel-Moneim, Irfan Khan, Ekaterina Ponomareva
Read the Full Article on Obesity Surgery

Title 2: Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis
Authors: Walter Ageno, Juan I Arcelus, Christine Stroh, Yasmina Djoudi, Mohamed Abdel-Moneim, Irfan Khan, Ekaterina Ponomareva, Marc Carrier
Read the Full Article on RPTH Journal

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 22, 2026, 21:06Marios Bantidos: Can a Routinely Available Metabolic Index Improve Prediction of Angiographic Outcomes in STEMI?
-
Jun 22, 2026, 20:53Kirti Gupta: What is a DVT Scan?
-
Jun 22, 2026, 20:47Ifeanyichukwu Ifechidere: Advancing Education, Research, and Laboratory Excellence in APS
-
Jun 22, 2026, 20:43Harshkumar Bhatiya: Stroke – Warning Signs, Prevention, and Immediate Medical Treatment
-
Jun 22, 2026, 16:45Shivangi Harankhedkar: Gene Therapy and CRISPR Advances in Hemoglobinopathies
-
Jun 22, 2026, 16:39Vikram Sinai Talaulikar: Haematology and Female Hormone Health Intersect at Multiple Levels
-
Jun 22, 2026, 16:35Sehrish Chaudhary: Advancing Transfusion Medicine Through Global Collaboration at ISBT 2026
-
Jun 22, 2026, 15:54Ready to Build Your ISTH 2026 Schedule?
-
Jun 22, 2026, 15:36Wolfgang Miesbach: What the Latest Gene Therapy Setbacks Mean for Haemophilia Care